LUCIUS 卢修斯 莫洛替尼 Momelotinib骨髓纤维化

莫洛替尼

美国FDA批准上市产品,疗效确切
卢修斯制药(老挝)有限公司出品

Momelotinib

老挝国家食药监局批准上市
老挝国家药检所检测认证

LUCIUS

骨髓纤维化

tach tilm-cuated tablet contains Momelotinib
dibydrochlorde monobydrate 121.94 mg cquvalent

PHARMACEUTICALS

uciMomelisa kinase inbibrtor indicated for the
treatment of intermediate or high-nisk myelofibros
NF), including primary MF or secoodary MF
[postpolyeythemia vera (PV) and post-essential
thrombocythemia (ET)L, in adults with anemi

LuciMomel

Dosage and Usc:
*Recomnended dosage: 200 ng orally once daily.
+Severe hepatie impairment (Child-Pagh Class C).

Momelotinib Tablets

FDA批准

Redace the starting dose to 150 mg orally once daily
Swallow tablets whole with or without fond
Storage: in a dry place and store at 20 C 1029

Warning

100 mg

Kecp medicine out of reach of Children. Do nol
ndmitister Luc Momelduring Pregnancy and Lactation
PLEASE SEE PACKAGE INSERT
Marufactured und Marketed by

Rx Only

LUCIUS

权威认证

Thongmang village. Xaythany district, Vientiane
Warning: Tobe sold by retail on prescrind
of renistered nbysicians onlo
nly, and as directal

30 Tablets

口碑质量

适应症:
适用于治疗中度或高风险骨髓纤维化(MF),包括原发性骨髓
纤维化或继发性骨髓纤维化[真性红细胞增多症(PV)和原发
性血小板增多症(ET)]的成人贫血患者。
推荐剂量:
1、每日口服一次,每次200mg,随餐或空腹均可。
2、严重肝损伤(Child-Pugh C级):将起始剂量降至150mg,
每日口服一次。